Clinical Trial Update: Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating an autologous dendritic cell vaccine in patients with soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Autologous dendritic cell vaccine (dendritic cell vaccine)

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Sarcoma, Neoplasms, Connective and Soft Tissue | Phase 1, Phase 2 | Status: UNKNOWN